However, adding HGF, which induces MET phosphorylation, overcame the inhibition of an ovarian cancer cell invasion caused by α5β1 blocking antibodies or siRNA, indicating that integrins act upstream of MET in an HGF-independent manner, playing a crucial role in MET activation [54]. The gene discussed is HGF; the disease is ovarian carcinoma.